Sustained Release with Intravitreal Administration DelSiTech’s Injectable Silica formulation is designed to provide long-acting drug release in the back of the eye, with durations ranging from a few weeks to six months or more. Key benefits include: - sustained drug release lasting several months - near zero-order release, supporting consistent release rates - low burst or burst-free release supporting controlled delivery - reduced administration frequency - minimal invasiveness, with administration via a 30-gauge needle
